A Trial of HRS5580 in Prevention of Postoperative Nausea and Vomiting of Adults
Status:
COMPLETED
Trial end date:
2024-10-29
Target enrollment:
Participant gender:
Summary
The study is being conducted to evaluate the efficacy, and safety of HRS5580 for preventing of postoperative nausea and vomiting in adults. To explore the reasonable dosage of HRS5580 for postoperative nausea and vomiting.